March 25, 2018 12:29 AM ET


Company Overview of Xalud Therapeutics, Inc.

Company Overview

Xalud Therapeutics, Inc. develops therapies for the treatment of neuro-inflammatory diseases. The company offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded in 2009 and is based in San Francisco, California.

30 Hill Street

San Francisco, CA 94110

United States

Founded in 2009



Key Executives for Xalud Therapeutics, Inc.

Vice President of Research & Development and Director
Chief Scientific Officer and Director
Compensation as of Fiscal Year 2017.

Xalud Therapeutics, Inc. Key Developments

Xalud Therapeutics, Inc. Presents at Annual Sofinnova Japan Biopharma Partnering Conference, Oct-25-2016 10:15 AM

Xalud Therapeutics, Inc. Presents at Annual Sofinnova Japan Biopharma Partnering Conference, Oct-25-2016 10:15 AM. Venue: Conrad Hotel, 1-9-1, Higashi-Shinbashi, Minato-Ku, Tokyo, 105 7337, Japan.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xalud Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at